INTRODUCTION
Severe sepsis and trauma are associated with protein catabolism, negative nitrogen balance and immunosuppression and represent a major threat to survival. Nutritional support in these circumstances maintains nitrogen balance and reduces both mortality and morbidity.1-4 However catabolism associated with sepsis is not reversed by standard hyperalimentation formulations.5 There is evidence that individual amino acids, used in pharmacological doses, may modify metabolism and modulate immune function during sepsis. Examples of such amino acids include, leucine, isoleucine and valine (branched chain amino acids) which inhibit muscle protein catabolism,6 glutamine which improves gut immune function7 and arginine which enhances systemic immune function.8 This review will concentrate on the metabolic effects of L-arginine, its significance as a substrate for nitric oxide synthesis and its potential as a pharmacological agent. ARGININE IN HEALTH Nutrition -Arginine is a dibasic nitrogen-rich molecule and although it can be synthesized endogenously in many mammals including humans,9 via the Krebs cycle, most is obtained from the diet. It shares an active transport system (y+) with other basic amino acids (lysine, ornithine and cystine) for absorption in the small intestine and there is also an active uptake mechanism within the kidney preventing excretion. Liver and kidney are both capable of synthesizing arginine from citrulline and ornithine via the urea cycle and by the same mechanism supply of arginine can control the synthesis of other amino acids ( Figure 1) . The liver has a relatively high concentration of the enzyme arginase (which degrades arginine into urea and ornithine), whereas renal arginase activity is low. The kidney therefore is the primary organ for conserving arginine. In health dietary arginine is not required for maintainance of nitrogen balance, but during growth or in illness and stress endogenous synthesis from citrulline is insufficient to meet body demands.""12 Thus arginine has been described as a semi-essential amino acid. In contrast, in vitro, arginine is an essential amino acid for cell culture systems'3 and is an essential precursor for polyamine, histone and nucleic acid synthesis which in turn are required for mitosis and manufacture of cellular proteins.
Secretagogue effects -Arginine is the most potent amino acid stimulator of insulin secretion when given either orally or intravenously.'4 There is however only a minor fall in plasma glucose concentrations due to simultaneous stimulation of growth hormone production.'5 Arginine also increases secretion of prolactin, 16 56 and with increased nitric oxide synthase activity,57 the involvement of nitric oxide in the disease process has been investigated. Supplemental 2% arginine in drinking water increases the severity of colitis with subsequent weight loss, thymolysis and splenolysis. This proinflammatory effect of arginine on the colonic mucosa is blocked by addition of the nitric oxide synthase inhibitor L-NAME (lOOmg/l) to the drinking water.58 Similar research using a model of ileitis has demonstrated a reduction in inflammation and mucosal nitrite production following inhibition of nitric oxide synthesis.59 This would suggest that nitric oxide is a major mediator in the mucosal inflammatory process and that its proinflammatory effects are increased by additional arginine in the diet.
CLINICAL APPLICATIONS OF L-ARGININE
The anticatabolic and immunostimulatory effects of arginine in cell culture systems and animal models have suggested that arginine has potential as a therapeutic agent in various clinical situations. Disadvantages of oral arginine treatment include its distinctive bitter taste, and increased gastrointestinal water excretion with resultant diarrhoea. Healthy Volunteers -in healthy humans, as in animal studies, oral arginine supplementation increases peripheral blood lymphocyte mitogenesis, decreases the number of T suppressor/cytotoxic cells and increases the T helper to T suppressor cell ratio. healing and the immune response to sepsis in experimental animals and humans. In animal models and in cell culture systems arginine increases macrophage activity against microorganisms and tumour cells. Therefore supplemental arginine may be of value in patients undergoing major surgery or following trauma and sepsis. Although more information is required arginine treatment may enhance adjuvant chemo therapy and radio therapy in malignant disease. An arginine/nitric oxide pathway has been demonstrated in most cells of the immune system, and nitric oxide may be the bioactive molecule by which arginine has its immune effects. Nitric oxide has important homeostatic roles, but increased production by immune cells may result in pathophysiological changes in conditions such as inflammatory bowel disease. In these conditions where increased production of nitric oxide is detrimental and stimulates the inflammatory process, systemic and topical administration of nitric oxide inhibitors may have therapeutic potential.
